Join your host, Henry Norton, and David Caumartin, the CEO of RebrAIn, as they discuss the impact that machine learning and artificial intelligence are having on the clinical outcomes of neurosurgery procedures. During the episode, David shares his medtech story, from how he entered the field to what drew him to RebrAIn several years ago. He also talks about his experience of working with neurosurgeons and how that differs from the other fields he specialised in, such as mammography. David goes on to discuss the benefits of AI in the surgical space, suggesting that it can improve surgeons’ accuracy, patient outcomes and medical research. He also touched on RebrAIn’s clinical trials and the findings that are emerging from them.
Podcast43
What's the Hype with Neuro? A Lesson in the Brain - With Hannah Claridge
In this episode, your host, Henry Norton, is joined by Hannah Claridge, the Head of Neurotechnology at TTP, to talk about the incredible advancements that are being made to treat neurological conditions. Hannah points out how complex the brain and nervous systems are, with both relying on intricate connections. She also explores the new technologies that are being developed to treat nervous disorders, such as spinal cord stimulation. She also compared neurotechnologies to pharmaceuticals, highlighting the parallels and differences in how they interact with the body. Hannah also suggested that neurotherapy will be key to the advancement of treatments for conditions like depression, due to their ability to provide targeted and long-term relief of symptoms. Cybersecurity is also a major concern for neurotechnology, as any malfunction or deliberate interference could have serious ramifications for patients.
